Cargando…

Antibodies to normal human melanocytes in vitiligo

Most patients with active vitiligo (82% of 61) have antibodies to antigens of normal human melanocytes that can be detected by specific immunoprecipitation of radioiodinated, detergent-soluble, melanocyte macromolecules. Such antibodies were present in only 12% of patients with melanoma and in none...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1983
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187087/
https://www.ncbi.nlm.nih.gov/pubmed/6345714
_version_ 1782146092985483264
collection PubMed
description Most patients with active vitiligo (82% of 61) have antibodies to antigens of normal human melanocytes that can be detected by specific immunoprecipitation of radioiodinated, detergent-soluble, melanocyte macromolecules. Such antibodies were present in only 12% of patients with melanoma and in none of 35 patients with nonpigmentary skin diseases. The antibodies were directed to a common antigen(s) on melanocytes that was not present on normal fibroblasts or keratinocytes. These observations suggest that vitiligo is an autoimmune disease mediated by antibodies to melanocyte-associated antigen(s).
format Text
id pubmed-2187087
institution National Center for Biotechnology Information
language English
publishDate 1983
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21870872008-04-17 Antibodies to normal human melanocytes in vitiligo J Exp Med Articles Most patients with active vitiligo (82% of 61) have antibodies to antigens of normal human melanocytes that can be detected by specific immunoprecipitation of radioiodinated, detergent-soluble, melanocyte macromolecules. Such antibodies were present in only 12% of patients with melanoma and in none of 35 patients with nonpigmentary skin diseases. The antibodies were directed to a common antigen(s) on melanocytes that was not present on normal fibroblasts or keratinocytes. These observations suggest that vitiligo is an autoimmune disease mediated by antibodies to melanocyte-associated antigen(s). The Rockefeller University Press 1983-07-01 /pmc/articles/PMC2187087/ /pubmed/6345714 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Antibodies to normal human melanocytes in vitiligo
title Antibodies to normal human melanocytes in vitiligo
title_full Antibodies to normal human melanocytes in vitiligo
title_fullStr Antibodies to normal human melanocytes in vitiligo
title_full_unstemmed Antibodies to normal human melanocytes in vitiligo
title_short Antibodies to normal human melanocytes in vitiligo
title_sort antibodies to normal human melanocytes in vitiligo
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187087/
https://www.ncbi.nlm.nih.gov/pubmed/6345714